News
-
-
-
-
REGULATED PRESS RELEASE
CHARGEURS - Calendrier de la réouverture de l’Offre Publique d’Achat sur les actions Chargeurs
Réouverture de l’Offre Publique d’Achat sur les actions Chargeurs suite au succès de l’OPA. Colombus Holding détiendra 65,56% du capital de Chargeurs. Calendrier de réouverture de 10 séances de bourse -
PRESS RELEASE
Final Bell Holdings International Completes Strategic Corporate Reorganization to Spearhead Transformative Growth
Final Bell Holdings International announces corporate reorganization with new subsidiary Final Bell Innovations consolidating non-plant touching business entities including 14th Round Inc. and Final Bell Brand Co. to drive growth and innovation in the cannabis industry -
PRESS RELEASE
bettermoo(d) CEO Announces Moodrink(TM) Stock-Up at United Natural Food (UNFI) Canada for Canada’s Largest Grocery Retail Chain
bettermoo(d) Food Corporation stocks flagship product Moodrink™ at United Natural Food (UNFI) Canada to meet demand of Canada's largest grocery retail chain. CEO Nima Bahrami praises product's reception and strategic move for nationwide presence -
PRESS RELEASE
NextGen Food Robotics Files Amended and Restated Interim Financial Statements and Management Discussions & Analyses
NextGen Food Robotics Corp. announces filing of amended financial statements for July 31, 2023, and October 31, 2023, revealing adjustments and improved financial positions -
PRESS RELEASE
Orogen Royalties Announces Preliminary 2023 Year End Financial Results
Orogen Royalties Inc. reports record revenue and profits in preliminary unaudited financial results for Q4-2023 and year ended December 31, 2023, showing significant increases. CEO comments on strong performance and future outlook -
-
PRESS RELEASE
EQS-Adhoc: Medios acquires Dutch market leader in pharmaceutical compounding services
Medios AG acquires Ceban Pharmaceuticals B.V., the Dutch market leader in pharmaceutical compounding services, in a strategic move to expand its business internationally and create a European Specialty Pharma platform